About the Journal

Revised Title Name from January 1, 2025

From January 1, 2025 the Journal of Kidney Cancer and VHL will publish with its revised title name of Journal of Kidney Cancer with same ISSN No 2203-5826.

Journal of Kidney Cancer  (ISSN: 2203-5826) is indexed in PubMed, Emerging
Read More

Current Issue

Vol. 12 No. 2 (2025): Journal of Kidney Cancer

Published: 2025-04-03

Editorial

Real-World Data as Real Evidence Showing Real-World Outcomes

Ulka Vaishampayan
Abstract 83 | PDF Downloads 66 XML Downloads 1 HTML Downloads 0

Page 46-47

Short Communication

Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations with Treatment Resistance in Clear Cell and Nonclear Cell Tumors

Wesley H. Chou, Nicholas H. Chakiryan, George V. Thomas
Abstract 217 | PDF Downloads 186 XML Downloads 3 HTML Downloads 0

Page 37-45

Kidney Cancer: Case Reports

Renal Cell Carcinoma Masquerading as Pyonephrosis — A Case Report of A Rare Presentation

Vishnu Pratap, Prakash Pawar, Ajit Sawant
Abstract 156 | PDF Downloads 99 HTML Downloads 0 XML Downloads 3

Page 10-13

Reno-Gonadal Venous Anastomosis for Right Renal Venous Drainage Following Juxtarenal Cavectomy for Renal Cell Carcinoma

Jabrina Simmons, Tae-Hee Kim, Tasha Posid, Shawn Dason
Abstract 78 | PDF Downloads 31 HTML Downloads 2 XML Downloads 2

Page 14-18

Kidney Cancer: Original Articles

Patient Perspective on Medical Conditions Post Immune Checkpoint Therapy in Advanced Renal Carcinoma

Ulka Vaishampayan, Sumanta Pal, Sephora Dafinescu, Neha Shah, Dena Battle, Michael Staehler
Abstract 168 | PDF Downloads 81 HTML Downloads 0 XML Downloads 23

Page 1-9

A Decade of Surgical Management of Renal Cell Carcinoma with IVC Thrombus and Bilateral Renal Tumors: Emphasis on Auto-transplantation

Abdul Rouf Khwaja, Aamir Mushtaq, Younis Mushtaq, Arif Hamid, Sajad Mali, Sajad Parra, Saqib Mehdi, Faheem ul Islam, Akil Lateif
Abstract 248 | PDF Downloads 182 HTML Downloads 0 XML Downloads 6

Page 19-26

First-Line Ipilimumab with Nivolumab versus Immune Checkpoint Inhibitors with Tyrosine Kinase Inhibitors in Patients with Intermediate- or Poor-Risk Metastatic Clear Cell Renal Cell Carcinoma

Micah Ostrowski, Yeonjung Jo, Georges Gebrael, Chadi Hage Chehade, Zeynep Irem Ozay, Blake Nordblad, Ayana Srivastava, Diya Garg, Richard Ji, Gliceida Galarza Fortuna, Vinay Mathew Thomas, Beverly Chigarira, Ethan Anderson, Neeraj Agarwal, Benjamin L. Maughan, Umang Swami
Abstract 112 | PDF Downloads 34 HTML Downloads 0 XML Downloads 2

Page 27-36

View All Issues